DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Neochem Bio Solutions Limited — Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter

NSE 1 hr ago·20 Oct 2026, 8:04 am

Neochem Bio Solutions

Neochem Bio Solutions Limited has filed its compliance report for corporate governance covering the quarter and half-year ending September 30, 2026. This document is a mandatory requirement for listed companies to demonstrate adherence to regulatory standards and internal governance protocols.

For investors, this filing is a routine administrative update that signals the company's continued compliance with market regulations. It does not indicate any specific operational changes or financial results, but it confirms that the company is maintaining the necessary governance structures in place.

Investors should continue to focus on the company's core business performance and future announcements for material information. This report is primarily a procedural update and does not alter the investment outlook.